Malaysian Stock: Duopharma Biotech Bhd.

Duopharma Biotech Berhad engages in the R&D and commercialization of chemical and pharmaceutical products.

Company: Duopharma Biotech Berhad

Bloomberg ticker: DBB MK

Market cap: US$454m

Background: Duopharma Biotech Berhad engages in the R&D and commercialization of chemical and pharmaceutical products. Its products include antibiotics, hemodialysis solution, sterile irrigation solution, sterile powder injectables, dental cartridges, and eye drop preparations. DBB is headquartered in Klang, Malaysia.

World Class Benchmarking of Duopharma Biotech

(Click on image to enlarge)

  • Profitable Growth rank of 5 was same compared to the prior period’s 5th rank
  • This is average performance compared to 410 medium Health Care companies worldwide
  • Profitability rank of 5 was the same as its Growth rank of 5
  • Profitability rank of 5 was the same compared to the prior period’s 5th rank
  • This is average performance compared to peers
  • Growth rank of 5 was the same compared to the prior period’s 5th rank
  • This is average performance compared to peers

Comments